Price target
29.500.00 0.00%
The 5 analysts offering 1 year price forecasts for 600196 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to 600196 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
600196 EPS for the last quarter is 0.23 CNY despite the estimation of 0.27 CNY. In the next quarter EPS is expected to reach 0.31 CNY. Track more of SHANGHAI FOSUN PHARMACEUTICAL (GROUP) financials and stay on top of what is up with the company.
In the next quarter SHANGHAI FOSUN PHARMACEUTICAL (GROUP) revenue is expected to reach 10.81 B CNY. Check out SHANGHAI FOSUN PHARMACEUTICAL (GROUP) revenue and earnings and make informed decisions.
According to analysts, 600196 price target is 29.50 CNY with a max estimate of 35.00 CNY and a min estimate of 24.50 CNY. Check if this forecast comes true in a year, meanwhile keep track of the current situation with 600196 news and stock market news.
We've gathered opinions of 6 analysts rating 600196 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.